May 8, 2018 / 10:22 AM / 6 months ago

BRIEF-Biocryst Pharmaceuticals Q1 Loss Per Share $0.26

May 8 (Reuters) - BioCryst Pharmaceuticals Inc:

* Q1 REVENUE VIEW $6 MILLION — THOMSON REUTERS I/B/E/S

* Q1 EARNINGS PER SHARE VIEW $-0.19 — THOMSON REUTERS I/B/E/S

* BIOCRYST CONTINUES TO EXPECT ITS 2018 NET OPERATING CASH USE TO BE IN RANGE OF $67 TO $90 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below